Natco Pharma on Wednesday, August 20, announced it has launched oral suspension tablets used in the treatment of pulmonary arterial hypertension (PAH).In an exchange...
Zydus Lifesciences has received its first-ever notice of compliance (NOC) from Health Canada for ZDS-varenicline tablets in 0.5 mg and 1 mg strengths.The tablets...
Marksans Pharma Ltd shares gained on Tuesday after its wholly owned UK subsidiary, Relonchem Ltd, secured Marketing Authorisation from the Medicines and Healthcare Products...
Global pharmaceutical giant Lupin Ltd. on Monday announced a significant milestone in its expansion strategy within the US market, securing tentative approval from the...